Drug Shortage Report for ISOPTIN SR
Report ID | 118074 |
Drug Identification Number | 01907123 |
Brand name | ISOPTIN SR |
Common or Proper name | VERAPAMIL HYDROCHLORIDE |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
Strength(s) | 120MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | C08DA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-09-02 |
Actual start date | 2020-06-29 |
Estimated end date | 2020-12-29 |
Actual end date | 2020-12-21 |
Shortage status | Resolved |
Updated date | 2020-12-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2020-12-22 | French | Compare |
v11 | 2020-12-22 | English | Compare |
v10 | 2020-12-08 | French | Compare |
v9 | 2020-12-08 | English | Compare |
v8 | 2020-12-01 | French | Compare |
v7 | 2020-12-01 | English | Compare |
v6 | 2020-11-25 | French | Compare |
v5 | 2020-11-25 | English | Compare |
v4 | 2020-06-30 | French | Compare |
v3 | 2020-06-30 | English | Compare |
v2 | 2020-06-17 | French | Compare |
v1 | 2020-06-17 | English | Compare |
Showing 1 to 12 of 12